等待開盤 01-29 09:30:00 美东时间
-0.710
-2.97%
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:CPRI) with a Market Perform and maintains $23 price target.
01-27 20:06
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose toward record highs on Thursday after President Do
01-23 02:42
FACTBOX-Oscar nominations 2026: nominees for 98th Academy Awards By Danielle Broadway LOS ANGELES, Jan 22 (Reuters) - Here is the list of Oscar nominees announced on Thursday with winners to be announced on March 15: BEST PICTURE "Bugonia" "F1" "Frankenstein" "Hamnet" "Marty Supreme" "One Battle Aft
01-22 22:48
UPDATE 1-Vampire thriller 'Sinners' leads all Oscar nominees with 16 nods Adds details in paragraph 1, additional nominees paragraphs 3-6 By Lisa Richwine LOS ANGELES, Jan 22 - 'Sinners,' a Segregation-era vampire thriller starring Michael B. Jordan, stormed into the awards race on Thursday with the
01-22 22:21
BWG Global upgrades Capri Holdings (NYSE:CPRI) from Negative to Mixed.
01-21 00:16
Capricor Therapeutics has provided regulatory updates on its Biologics License Application (BLA) for Deramiocel, a cell therapy for Duchenne muscular dystrophy (DMD). The FDA has requested the full HOPE-3 clinical study report (CSR) and supporting data to address the Complete Response Letter (CRL). The company plans to submit the requested materials in February 2026, aiming to support continued FDA review and potentially secure a new PDUFA target...
01-20 14:15
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
Jefferies analyst Blake Anderson assumes Capri Holdings (NYSE:CPRI) with a Hold rating and announces Price Target of $24.
01-14 21:49